These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 18996742

  • 1. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L, Eriksson M, Cornette F, Santoro F, Muscat N, Luthinger R, Roth T.
    Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
    [Abstract] [Full Text] [Related]

  • 2. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia.
    Staner C, Joly F, Jacquot N, Vlasova ID, Nehlin M, Lundqvist T, Edenius C, Staner L.
    Curr Med Res Opin; 2010 Jun; 26(6):1423-31. PubMed ID: 20397964
    [Abstract] [Full Text] [Related]

  • 3. Lower doses of sublingual Zolpidem are more effective than oral Zolpidem to anticipate sleep onset in healthy volunteers.
    Valente KD, Hasan R, Tavares SM, Gattaz WF.
    Sleep Med; 2013 Jan; 14(1):20-3. PubMed ID: 23218533
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB, Roth T, Vogel GW, Walsh JK.
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [Abstract] [Full Text] [Related]

  • 7. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 8. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
    Parrino L, Smerieri A, Giglia F, Milioli G, De Paolis F, Terzano MG.
    Clin Neuropharmacol; 2008 Jul; 31(1):40-50. PubMed ID: 18303490
    [Abstract] [Full Text] [Related]

  • 9. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
    Blumer JL, Findling RL, Shih WJ, Soubrane C, Reed MD.
    Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468
    [Abstract] [Full Text] [Related]

  • 10. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.
    Staner L, Danjou P, Luthringer R.
    Expert Rev Neurother; 2012 Feb; 12(2):141-53. PubMed ID: 22288669
    [Abstract] [Full Text] [Related]

  • 11. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G, Hedner J, Eglin M, Loft H, Stórustovu SI, Lütolf S, Lundahl J, Gaboxadol Study 99775 Group.
    Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
    [Abstract] [Full Text] [Related]

  • 12. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
    Roth T, Hull SG, Lankford DA, Rosenberg R, Scharf MB, Intermezzo Study Group.
    Sleep; 2008 Sep; 31(9):1277-84. PubMed ID: 18788653
    [Abstract] [Full Text] [Related]

  • 13. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
    Monti JM, Alvariño F, Monti D.
    Sleep; 2000 Dec 15; 23(8):1075-84. PubMed ID: 11145322
    [Abstract] [Full Text] [Related]

  • 14. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 15; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 15. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
    Ozone M, Yagi T, Itoh H, Tamura Y, Inoue Y, Uchimura N, Sasaki M, Shimizu T, Terzano MG, Parrino L.
    Pharmacopsychiatry; 2008 May 15; 41(3):106-14. PubMed ID: 18484552
    [Abstract] [Full Text] [Related]

  • 16. Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle-of-the-night awakening in insomnia.
    Roth T, Steinberg F, Singh NN, Moline M.
    Hum Psychopharmacol; 2014 Jan 15; 29(1):25-30. PubMed ID: 24424704
    [Abstract] [Full Text] [Related]

  • 17. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
    Jhaveri M, Seal B, Pollack M, Wertz D.
    Curr Med Res Opin; 2007 Jun 15; 23(6):1431-43. PubMed ID: 17559740
    [Abstract] [Full Text] [Related]

  • 18. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC.
    Sleep; 2000 Dec 15; 23(8):1087-96. PubMed ID: 11145323
    [Abstract] [Full Text] [Related]

  • 19. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH, Burke PJ.
    Curr Med Res Opin; 2008 Mar 15; 24(3):837-46. PubMed ID: 18257978
    [Abstract] [Full Text] [Related]

  • 20. Dose response effects of zolpidem in normal geriatric subjects.
    Scharf MB, Mayleben DW, Kaffeman M, Krall R, Ochs R.
    J Clin Psychiatry; 1991 Feb 15; 52(2):77-83. PubMed ID: 1993640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.